The US District Court for the District of Delaware has upheld the validity of a GSK-held patent that covers two HIV drugs marketed in the US by ViiV Healthcare.
If you have already subscribed please login.
If you have any technical issues please email tech support.
ViiV Healthcare, GSK, Teva, pharmaceuticals, patent validity
